An observational study in Cognitive Decline, Mild, sponsored by Soroka University Medical Center. Active, not recruiting at 1 site in Israel. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.
Sponsored by Soroka University Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Cognitive Dysfunction with a site in Israel — 6 open to participants now, 8 under way, none of them phase 3. Cognitive Dysfunction · Israel.
Among the 54 studies in Cognitive Dysfunction with a site in Israel, this one is the 11th largest by enrollment of the 20 observational ones that give a count, is one of 4 that started in 2024, is one of 20 observational ones, and was the 53rd registered.
3,876 studies on the registry are indexed under Cognitive Dysfunction; 1,119 are open to participants now.
Browse Cognitive Dysfunction studies →6 of the 54 studies in Cognitive Dysfunction with a site in Israel are open now. Recruiting first, the newest first:
Hadassah Medical Organization · Sites in Israel
Ages 18+ · Women only
Rutgers, The State University of New Jersey · Sites in Israel
Ages 60–90
Assaf-Harofeh Medical Center · Sites in Israel
Ages 60–85
Rambam Health Care Campus · Sites in Israel
Ages 18+ · Healthy volunteers
Hadassah Medical Organization · Sites in Israel
Ages 65+
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 753 Cognitive Dysfunction studies recruiting now, 364 (48%) set no upper age limit and 143 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 3 · Phase 4 1
First in 2000; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 98 is below the median of 150 across 998 observational studies indexed under Cognitive Dysfunction.
Median enrollment 50 across the 34 interventional studies, 99 across the 20 observational. Of the 23 that completed or were terminated, 5 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 54 have an industry lead sponsor. The 10 most frequent:
Soroka University Medical Center is the lead sponsor of 160 studies on the registry; 2 are open to participants now.
Soroka University Medical Center has 1 study filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
3 of the studies in Cognitive Dysfunction with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07287852Hadassah Medical OrganizationA Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI | 2026-12 |
| NCT07596186Soroka University Medical CenterPredict Early Cognitive Changes in a Healthy Elderly Population by Passively Recording Sensor Data From Mobile Devices | 2027-01-01 |
| NCT07591857Hadassah Medical OrganizationThe Computerized Retraining and Functional Treatment - Group Intervention | 2027-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 54 studies in Cognitive Dysfunction with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study will recruit 100 participants aged 65+ residing in assisted living facilities. Eligible participants will undergo an initial cognitive assessment to document their baseline cognitive status using cognitive tests conducted either in their assisted living facility or at Soroka Medical Center. An app designed for research data collection (Aware-Light) will be installed on participants' mobile devices, collecting data only after participants provide consent. Over three months, the app will automatically gather sensor data, including movement data from the accelerometer, orientation data from the gravity sensor, rotation data from the gyroscope, proximity data for measuring distance from nearby objects, ambient light levels from the light sensor, and typing dynamics such as typing frequency and duration without recording actual text. The app will also track app usage, including activation, pauses, closures, background activity, notifications, and crashes, as well as air pressure through the barometer, phone capabilities through the telephony detector, and screen states such as on, locked, or off. It will log communication events such as calls and messages without recording personal details, monitor vehicle speed through the linear accelerometer, track rotation angles through the rotation detector, and identify significant movements like walking, cycling, or traveling. No typed data, such as passwords, will be collected. After one month, the research team will contact participants to ensure the app functions correctly. After three months, participants will undergo a second cognitive assessment, and the app will be uninstalled.
Tenants in assisted living housing
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prediction model of mobile device data, collected for 9 months of lower scores in Neurotrax cognitive assessment compared to baseline evaluation.
Mobile device sensor data
Time frame: Baseline and 9 Month after
Started Dec 2024 (actual). Primary completion is estimated for Jan 2027, 25 months after the start.
Of 505 non-industry observational studies under Cognitive Dysfunction, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 118. This study's planned 25 months is below that.
Counting every sponsor, half of 544 studies reached it within 47 months; a quarter within 21 and three quarters within 118.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Soroka University Medical Center →